NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National
Buyers
Value
£261,895,933
Suppliers
- Roche Products Ltd
- Amgen Ltd
- Seqirus UK Limited
- Biogen
- Teva UK Limited
- Dr.Reddy's Laboratories (UK) Limited
- Orifarm UK
- Pfizer Ltd
- Vifor Pharma UK Ltd
- ACCORD-UK LTD
- Sandoz Ltd
- Eli Lilly & Company Ltd
- Chugai Pharma UK Ltd
- Mylan
- Aventis Pharma ltd t/a Sanofi
- Manx Healthcare Ltd
- Janssen-Cilag Ltd
- Novo Nordisk
- Sun Pharma UK Ltd
- Merck Serono Limited
- Bayer plc
- Napp Pharmaceuticals Ltd
- AstraZeneca
- CST Pharma Limited
- Pharmacosmos UK Ltd
- Thornton and Ross Ltd
- GLAXOSMITHKLINE UK LIMITED
- Gedeon Richter UK Ltd
Classifications
- Pharmaceutical products
Tags
- award
Submission Deadline
4 months ago
Published
3 days ago
Description
NHS Framework Agreement for Branded Medicines - Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 Offer reference number: CM/PHR/24/5718 CM/PHR/24/5718/01 - NHS Framework Agreement for Branded Medicines - Tranche A for London and South of England. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5718/02 - NHS Framework Agreement for Branded Medicines - Adult Influenza (National). Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months.
Similar Contracts
AI Bid Assistant
Our AI-powered tool to help you create winning bids is coming soon!
Timeline complete
Complete